The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial
Padungkeat Karasin, Kittithat Tantitanawat, Chanchai Charonpongsuntorn, Anuchit Suksamai, Sakkarin Chirapongsathorn. The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial. // Asia-Pacific Journal of Clinical Oncology. – 2026. – DOI: 10.1111/ajco.70127. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70127?af=R
Padungkeat Karasin, Kittithat Tantitanawat, Chanchai Charonpongsuntorn, Anuchit Suksamai, & Sakkarin Chirapongsathorn (2026). The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70127
Padungkeat Karasin, et al. “The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial.” Asia-Pacific Journal of Clinical Oncology, 2026. doi:10.1111/ajco.70127.
@article{Karasin2026,
title = {The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial},
author = {Karasin, Padungkeat and Tantitanawat, Kittithat and Charonpongsuntorn, Chanchai and Suksamai, Anuchit and Chirapongsathorn, Sakkarin},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70127},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ajco.70127?af=R}
}